Controlled delivery of the antiprotozoal agent (tinidazole) from intravaginal polymer matrices for treatment of the sexually transmitted infection, trichomoniasis

References

• Al-Munajjed AA, Hien M, Kujat R, Gleeson JP, Hammer J. 2008. Influence of pore size on tensile strength, permeability and porosity of hyaluronan-collagen scaffolds. J Mater Sci: Mater Med. 19:2859–2864.
   PubMed Web of Science ®Google Scholar
• Asvadi NH, Dang NTT, Davis-Poynter N, Coombes AGA. 2013. Evaluation of microporous polycaprolactone matrices for controlled delivery of antiviral microbicides to the female genital tract. J Mater Sci: Mater Med. 24:2719–2727.
   PubMed Web of Science ®Google Scholar
• Bakshi M, Singh S. 2004. HPLC and LC-MS studies on stress degradation behaviour of tinidazole and development of a validated specific stability-indicating HPLC assay method. J Pharm Biomed Anal. 34:11–18.
   PubMed Web of Science ®Google Scholar
• Castillo M, et al. 2010. Experimental study of the dielectric behavior of tinidazole in acetone at 25 °C. Vitae, Revista De La Facultad De Quimica Farmaceutica. 17:299–308.
   Google Scholar
• Centers for Disease Control and Prevention. 2015. Sexually transmitted diseases treatment guidelines. Trichomoniasis.
   Google Scholar
• Chang HI, Perrie Y, Coombes AG. 2006. Delivery of the antibiotic gentamicin sulphate from precipitation cast matrices of polycaprolactone. J Control Release. 110:414–421.
   PubMed Web of Science ®Google Scholar
• Chang H-I, Williamson MR, Perrie Y, Coombes AGA. 2005. Precipitation casting of drug-loaded microporous PCL matrices: incorporation of progesterone by co-dissolution. J Control Release. 106:263–272.
   PubMed Web of Science ®Google Scholar
• Costa P, Sousa Lobo JM. 2001. Modeling and comparison of dissolution profiles. Eur J Pharm Sci. 13:123–133.
   PubMed Web of Science ®Google Scholar
• Cudmore SL, Delgaty KL, Hayward-McClelland SF, Petrin DP, Garber GE. 2004. Treatment of infections caused by metronidazole-resistant trichomonas vaginalis. Clin Microbiol Rev. 17:783–793.
   PubMed Web of Science ®Google Scholar
• Dang N, Sivakumaran H, Harrich D, Shaw PN, Coombes AGA. 2014. Evaluation of polycaprolactone matrices for sustained vaginal delivery of nevirapine in the prevention of heterosexual HIV transmission. J Pharm Sci. 103:2107–2115.
   PubMed Web of Science ®Google Scholar
• Dang NT, Turner MS, Coombes AG. 2013. Development of intra-vaginal matrices from polycaprolactone for sustained release of antimicrobial agents. J Biomater Appl. 28:74–83.
   PubMed Web of Science ®Google Scholar
• Dang NTT, Sivakumaran H, Harrich D, Coombes AGA. 2013. An evaluation of polycaprolactone matrices for vaginal delivery of the antiviral, tenofovir, in preventing heterosexual transmission of HIV. J Pharm Sci. 102:3725–3735.
   PubMed Web of Science ®Google Scholar
• Das S, Huengsberg M, Shahmanesh M. 2005. Treatment failure of vaginal trichomoniasis in clinical practice. Int J Std Aids. 16:284–286.
   PubMed Web of Science ®Google Scholar
• Friend DR. 2010. Pharmaceutical development of microbicide drug products. Pharm Dev Technol. 15:562–581.
   PubMed Web of Science ®Google Scholar
• Gardner TB, Hill DR. 2001. Treatment of giardiasis. Clin Microbiol Rev. 14:114–128.
   PubMed Web of Science ®Google Scholar
• Higuchi T. 1963. Mechanism of sustained-action medication. theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci. 52:1145–1149.
   PubMed Web of Science ®Google Scholar
• Malcolm RK, Edwards K-L, Kiser P, Romano J, Smith TJ. 2010. Advances in microbicide vaginal rings. Antiviral Res. 88:S30–S39.
   PubMed Web of Science ®Google Scholar
• Mayaud P, Mabey D. 2004. Approaches to the control of sexually transmitted infections in developing countries: old problems and modern challenges. Sex Transm Infect. 80:174–182.
   PubMed Web of Science ®Google Scholar
• Meingassner JG, Thurner J. 1979. Strain of trichomonas-vaginalis resistant to metronidazole and other 5-nitroimidazoles. Antimicrob Agents Chemother. 15:254–257.
   PubMed Web of Science ®Google Scholar
• Miyajima M, Koshika A, Okada J, Kusai A, Ikeda M. 1998. Factors influencing the diffusion-controlled release of papaverine from poly (L-lactic acid) matrix. J Control Release.. 56:85–94.
   PubMed Web of Science ®Google Scholar
• Nord CE, Kager L. 1983. Tinidazole–microbiology, pharmacology and efficacy in anaerobic infections. Infection. 11:54–60.
   PubMed Web of Science ®Google Scholar
• Owen DH, Katz DF. 1999. A vaginal fluid simulant. Contraception. 59:91–95.
   PubMed Web of Science ®Google Scholar
• Pathak M, Coombes AGA, Ryu BMi, Cabot PJ, Turner MS, Palmer C, Wang D, Steadman KJ. 2018. Sustained simultaneous delivery of metronidazole and doxycycline from polycaprolactone matrices designed for intravaginal treatment of pelvic inflammatory disease. J Pharm Sci. 107:863–869.
   PubMed Web of Science ®Google Scholar
• Pathak M, Coombes AGA, Turner MS, Palmer C, Wang D, Steadman KJ. 2015. Investigation of polycaprolactone matrices for intravaginal delivery of doxycycline. J Pharm Sci. 104:4217–4222.
   PubMed Web of Science ®Google Scholar
• Pathak M, Turner M, Palmer C, Coombes AGA. 2014. Evaluation of polycaprolactone matrices for the intravaginal delivery of metronidazole in the treatment of bacterial vaginosis. J Biomater Appl. 29:354–363.
   PubMed Web of Science ®Google Scholar
• Salo JPK, Yli-Kauhaluoma J, Salomies H. 2003. On the hydrolytic behavior of tinidazole, metronidazole, and ornidazole. J Pharm Sci. 92:739–746.
   PubMed Web of Science ®Google Scholar
• Sears SD, O’Hare J. 1988. In vitro susceptibility of Trichomonas vaginalis to 50 antimicrobial agents. Antimicrob Agents Chemother. 32:144–146.
   PubMed Web of Science ®Google Scholar
• Shalaby WS, Shalaby SW. 1998. Key features and future perspectives in the development of intravaginal drug delivery systems. In: McCulloch I, Shalaby SW, editors. Tailored polymeric materials for controlled delivery systems. Oxford University Press. p. 23–53.
   Google Scholar
• Sutton M, Sternberg M, Koumans EH, McQuillan G, Berman S, Markowitz L. 2007. The prevalence of Trichomonas vaginalis infection among reproductive-age women in the United States, 2001-2004. Clin Infect Dis. 45:1319–1326.
   PubMed Web of Science ®Google Scholar
• Van Der Pol B. 2007. Trichomonas vaginalis infection: the most prevalent nonviral sexually transmitted infection receives the least public health attention. Clin Infect Dis.. 44:23–25.
   PubMed Web of Science ®Google Scholar
• Wang Y, Chang H-I, Li X, Alpar O, Coombes AGA. 2009. Delivery of bioactive macromolecules from microporous polymer matrices: release and activity profiles of lysozyme, collagenase and catalase. Eur J Pharm Sci. 37:387–394.
   PubMed Web of Science ®Google Scholar
• Wang Y, Wertheim DF, Jones AS, Chang H-I, Coombes AGA. 2010. Micro-CT analysis of matrix-type drug delivery devices and correlation with protein release behaviour. J Pharm Sci. 99:2854–2862.
   PubMed Web of Science ®Google Scholar
• Woodruff MA, Hutmacher DW. 2010. The return of a forgotten polymer-polycaprolactone in the 21st century. Prog Polym Sci. 35:1217–1256.
   Web of Science ®Google Scholar
• Woolfson AD, Malcolm RK, Morrow RJ, Toner CF, McCullagh SD. 2006. Intravaginal ring delivery of the reverse transcriptase inhibitor TMC 120 as an HIV microbicide. Int J Pharm. 325:82–89.
   PubMed Web of Science ®Google Scholar
• Yang J, McCoy BJ, Madras G. 2005. Temperature effects for isothermal polymer crystallization kinetics. J Chem Phys. 122:244905.
   PubMed Web of Science ®Google Scholar